Skip to content

FOLD

Amicus Therapeutics, Inc.

NASDAQ · Healthcare · Biotechnology · US

$14.49
+0.00%
Ask drillr
0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+1.5%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Mar 4, 2026Campbell Bradley L · director, officer: President and CEOSale22,500$14
Jan 22, 2026Campbell Bradley L · director, officer: President and CEOM-Exempt75,000$6.10
Jan 22, 2026Campbell Bradley L · director, officer: President and CEOSale75,000$14
Jan 6, 2026Castelli Jeff · officer: Chief Development OfficerF-InKind23,102$14
Jan 6, 2026Prout Samantha · officer: Chief Accounting OfficerF-InKind12,240$14
Jan 6, 2026Castelli Jeff · officer: Chief Development OfficerF-InKind6,905$14
Jan 6, 2026Clark David Michael · officer: Chief People OfficerF-InKind5,381$14
Jan 6, 2026Prout Samantha · officer: Chief Accounting OfficerF-InKind3,443$14
Jan 6, 2026Rosenberg Ellen · officer: Chief Legal OfficerF-InKind13,426$14
Jan 6, 2026Clark David Michael · officer: Chief People OfficerF-InKind18,498$14
Jan 6, 2026Rosenberg Ellen · officer: Chief Legal OfficerF-InKind29,683$14
Dec 30, 2025Campbell Bradley L · director, officer: President and CEOF-InKind108,602$14
Dec 30, 2025Harford Simon N.R. · officer: Chief Financial OfficerF-InKind71,303$14
Dec 23, 2025Clark David Michael · officer: Chief People OfficerSale25,642$14
Dec 17, 2025Clark David Michael · officer: Chief People OfficerSale25,643$11
Dec 17, 2025Campbell Bradley L · director, officer: President and CEOM-Exempt70,426$9.03
Dec 17, 2025Campbell Bradley L · director, officer: President and CEOSale77,926$11
Dec 3, 2025Prout Samantha · officer: Chief Accounting OfficerA-Award32,193$0.00
Dec 3, 2025Campbell Bradley L · director, officer: President and CEOSale14,587$10
Dec 3, 2025Campbell Bradley L · director, officer: President and CEOM-Exempt14,587$9.03
Nov 26, 2025Rosenberg Ellen · officer: Chief Legal OfficerM-Exempt11,000$5.13
Nov 26, 2025Campbell Bradley L · director, officer: President and CEOSale14,587$10
Nov 26, 2025Rosenberg Ellen · officer: Chief Legal OfficerM-Exempt25,000$6.10
Nov 26, 2025Rosenberg Ellen · officer: Chief Legal OfficerSale23,621$10
Nov 26, 2025Castelli Jeff · officer: Chief Development OfficerM-Exempt50,000$9.03
Nov 26, 2025Rosenberg Ellen · officer: Chief Legal OfficerM-Exempt23,621$5.13
Nov 26, 2025Castelli Jeff · officer: Chief Development OfficerSale76,158$10
Nov 26, 2025Rosenberg Ellen · officer: Chief Legal OfficerSale36,000$10
Nov 26, 2025Clark David Michael · officer: Chief People OfficerSale25,643$10
Nov 26, 2025Campbell Bradley L · director, officer: President and CEOM-Exempt14,587$9.03
Institutional positioning

13F filings over the trailing two quarters

New 53Increased 107Reduced 95Sold out 297
FilerActionSharesFiled
BLACKROCK, INC.Increased33,879,048May 13, 2026
UBS GROUP AGIncreased15,957,913May 5, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position14,023,557May 15, 2026
PENTWATER CAPITAL MANAGEMENT LPIncreased14,000,000May 15, 2026
VANGUARD PORTFOLIO MANAGEMENT LLCNew Position13,974,932May 8, 2026
STATE STREET CORPReduced12,893,897May 15, 2026
GLAZER CAPITAL, LLCIncreased12,722,749May 14, 2026
FIL LTDIncreased12,560,028May 15, 2026
GOLDMAN SACHS GROUP INCReduced11,556,008May 15, 2026
QUBE RESEARCH & TECHNOLOGIES LTDIncreased8,809,340May 15, 2026
HBK INVESTMENTS L PReduced8,783,448May 15, 2026
GEODE CAPITAL MANAGEMENT, LLCIncreased8,535,918May 15, 2026
O'Connor Alternative Investments LLCNew Position8,444,992May 15, 2026
MILLENNIUM MANAGEMENT LLCIncreased7,908,459May 15, 2026
MORGAN STANLEYReduced6,998,884May 15, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Mar 4, 2026